Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China
Frontiers of Medicine · 2024
DOI: 10.1007/s11684-024-1063-9 ↗Kurz gefasst
Leserbrief in der Zeitschrift Frontiers of Medicine, 2024. Verfasst von Yihui Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China.
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, 410008, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
- Furong Laboratory, Changsha, 410008, China.
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, 410008, China. xylijie@csu.edu.cn.
- Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, 410008, China. xylijie@csu.edu.cn.
Zitieren
APA
Chen, Y., Cao, Q., Peng, C., Zhou, B., Jiang, Y., Chen, X., & Li, J. (2024). Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China. Frontiers of Medicine. https://doi.org/10.1007/s11684-024-1063-9
Vancouver
Chen Y, Cao Q, Peng C, Zhou B, Jiang Y, Chen X, et al. Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China. Frontiers of Medicine. 2024. doi:10.1007/s11684-024-1063-9
BibTeX
@article{Chen2024,
author = {Chen, Yihui and Cao, Qiaozhi and Peng, Cong and Zhou, Bingjing and Jiang, Yu and Chen, Xiang and Li, Jie},
title = {Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China},
journal = {Frontiers of Medicine},
year = {2024},
doi = {10.1007/s11684-024-1063-9}
}
EUVIMED